Home > Publications database > Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.
 
Journal Article (Letter) DKFZ-2025-01049
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Wiley Hoboken, NJ

Cancer communications 45(8), 966-970 () [10.1002/cac2.70029]
 GO

Classification:

Note: Volume 45, Issue 8 pp. 966-970
Contributing Institute(s):
  1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)
  2. DKTK Koordinierungsstelle Frankfurt (FM01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database
 Record created 2025-05-21, last modified 2025-09-05
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio 1.1.7-dirty
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy